The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog portein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.

Ruat, M., Faure, H., Traiffort, E., Schoenfelder, A., Mann, A., Taddei, M., et al. (2015)N-Actylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway. . Brevetto No. US9073835B2.

N-Actylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway

TADDEI, MAURIZIO;MANETTI, FABRIZIO
2015-01-01

Abstract

The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog portein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.
2015
Ruat, M., Faure, H., Traiffort, E., Schoenfelder, A., Mann, A., Taddei, M., et al. (2015)N-Actylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway. . Brevetto No. US9073835B2.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/989878
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo